5th Dec 2007 07:00
TATE & LYLE BOARD CHANGE Tate & Lyle PLC announces that Kai Nargolwala has decided to step down as a Non-Executive Director with effect from 31 December 2007. Mr Nargolwala is based in Singapore and, as previously announced, will bejoining the Credit Suisse Group as Chief Executive Officer of the Asia-PacificRegion on 1 January 2008. The requirements of this new executive role mean that he will nolonger be able to commit the required time to travel to the UK on a regularbasis to attend Tate & Lyle Board meetings. This has prompted his decision tostep down. Sir David Lees, Chairman of Tate & Lyle, said: "I am very sorry that Kai's newwork commitments make it necessary for him to step down from the Board. We thankhim for his excellent contribution over the past three years and wish him everysuccess in the future." Kai Nargolwala said, "I am disappointed that the time commitments of my newexecutive role mean I have to step down from the Board. I greatly enjoyed mytime with Tate & Lyle and wish the Company every success in the future". END CONTACTS Rowan Adams, Director of Corporate CommunicationsTel: 020 7626 6525 Tim Lodge, Director of Investor RelationsTel: 020 7626 6525 or Mobile: 07798 837317 About Tate & Lyle: Tate & Lyle is a world leading manufacturer of renewable food and industrialingredients. It uses innovative technology to transform corn and sugar intovalue-added ingredients for customers in the food, beverage, pharmaceutical,cosmetic, paper, packaging and building industries. The Company is a leader incereal sweeteners and starches, sugar refining, value added food and industrialingredients, and citric acid. Tate & Lyle is the world number-one in industrialstarches and is the sole manufacturer of SPLENDA(R) Sucralose. Headquartered in London, Tate & Lyle is listed on the London Stock Exchangeunder the symbol TATE.L. In the US its ADRs trade under TATYY. The Companyoperates more than 50 production facilities throughout Europe, the Americas andSouth East Asia. In the year to 31 March 2007, it employed 6,900 people in itssubsidiaries with a further 2,300 employed in joint ventures. Sales in the yearto 31 March 2007 totalled £4.0 billion. Additional information can be found onhttp://www.tateandlyle.com. SPLENDA(R) is a trademark of McNeil Nutritionals, LLC Copyright Business Wire 2007Related Shares:
Tate & Lyle